Alessio Ciulli

Citado por

	Total	Desde 2020
Citas	13019	9382
Índice h	60	46
Índice i10	114	104

2400

1200

600

1800

200720082009201020112012201320142015201620172018201920202021202220232024202543 43 49 62 71 113 129 184 267 352 504 734 967 1421 1456 1805 1971 2348 367

Acceso público

Ver todo

108 artículos

4 artículos

disponibles

no disponibles

Basado en requisitos de financiación

Coautores

Andrea TestaTRIMTECH THERAPEUTICSDirección de correo verificada de trimtechtherapeutics.com
Scott J. HughesUniversity of DundeeDirección de correo verificada de dundee.ac.uk
Chiara ManiaciUniversity of DundeeDirección de correo verificada de dundee.ac.uk
Tom L BlundellEmeritus Professor of Biochemistry, University of CambridgeDirección de correo verificada de cam.ac.uk
Xavier LucasComputational medicinal chemist at Monte Rosa Therapeutics, BaselDirección de correo verificada de monterosatx.com
Dennis BuckleyNIBRDirección de correo verificada de novartis.com
Craig CrewsYale UniversityDirección de correo verificada de yale.edu
William L. JorgensenSterling Professor of Chemistry, Yale UniversityDirección de correo verificada de yale.edu
Sonia RochaDepartment of Biochemistry, Cell and Systems Biology, ISMIB, University of LiverpoolDirección de correo verificada de liverpool.ac.uk
Carles GaldeanoSerra Hunter Lecturer Professor at University of BarcelonaDirección de correo verificada de ub.edu
William FarnabyUniversity of DundeeDirección de correo verificada de dundee.ac.uk
Danette DanielsGroup Leader, Promega CorporationDirección de correo verificada de promega.com
Dario AlessiMRC Protein Phosphorylation and Ubiquitylation Units, University of DundeeDirección de correo verificada de dundee.ac.uk
Matthias BaudUniversity of SouthamptonDirección de correo verificada de soton.ac.uk
Prof. Alison G. SmithDept of Plant Sciences, University of CambridgeDirección de correo verificada de cam.ac.uk
Panagis FilippakopoulosAssociate Professor, Oxford UniversityDirección de correo verificada de sgc.ox.ac.uk
Fleur M. FergusonUniversity of California, San DiegoDirección de correo verificada de ucsd.edu
Oleg FedorovUniversity of OxfordDirección de correo verificada de cmd.ox.ac.uk
Georg E WinterPrincipal Investigator at CeMM, ViennaDirección de correo verificada de cemm.oeaw.ac.at
Dr Ola EpemoluPrincipal Research Scientist in In vitro/In vivo DMPK -CRLDirección de correo verificada de crl.com

Seguir

Alessio Ciulli

Professor, University of Dundee

Dirección de correo verificada de dundee.ac.uk - Página principal

Chemical Biology Structural Biology Medicinal Chemistry Drug Discovery Targeted Protein Degradation


Título Ordenar por citas Ordenar por año Ordenar por título	Citado por Citado por	Año
Structural basis of PROTAC cooperative recognition for selective protein degradation MS Gadd, A Testa, X Lucas, KH Chan, W Chen, DJ Lamont, M Zengerle, ... Nature chemical biology 13 (5), 514-521, 2017	1097	2017
Selective small molecule induced degradation of the BET bromodomain protein BRD4 M Zengerle, KH Chan, A Ciulli ACS chemical biology 10 (8), 1770-1777, 2015	1049	2015
Targeting the von Hippel–Lindau E3 ubiquitin ligase using small molecules to disrupt the VHL/HIF-1α interaction DL Buckley, I Van Molle, PC Gareiss, HS Tae, J Michel, DJ Noblin, ... Journal of the American Chemical Society 134 (10), 4465-4468, 2012	591	2012
BAF complex vulnerabilities in cancer demonstrated via structure-based PROTAC design W Farnaby, M Koegl, MJ Roy, C Whitworth, E Diers, N Trainor, D Zollman, ... Nature chemical biology 15 (7), 672-680, 2019	496	2019
Structure-guided design and optimization of small molecules targeting the protein–protein interaction between the von Hippel–Lindau (VHL) E3 ubiquitin ligase and the hypoxia … C Galdeano, MS Gadd, P Soares, S Scaffidi, I Van Molle, I Birced, ... Journal of Medicinal Chemistry 57 (20), 8657-8663, 2014	442	2014
Small Molecule Inhibitors of the Interaction Between the E3 Ligase VHL and HIF1α DL Buckley, JL Gustafson, I Van Molle, AG Roth, HS Tae, PC Gareiss, ... Angewandte Chemie (International Ed. in English) 51 (46), 11463, 2012	354	2012
Iterative design and optimization of initially inactive proteolysis targeting chimeras (PROTACs) identify VZ185 as a potent, fast, and selective von Hippel–Lindau (VHL) based … V Zoppi, SJ Hughes, C Maniaci, A Testa, T Gmaschitz, C Wieshofer, ... Journal of medicinal chemistry 62 (2), 699-726, 2018	319	2018
SPR-measured dissociation kinetics of PROTAC ternary complexes influence target degradation rate MJ Roy, S Winkler, SJ Hughes, C Whitworth, M Galant, W Farnaby, ... ACS chemical biology 14 (3), 361-368, 2019	297	2019
Homo-PROTACs: bivalent small-molecule dimerizers of the VHL E3 ubiquitin ligase to induce self-degradation C Maniaci, SJ Hughes, A Testa, W Chen, DJ Lamont, S Rocha, DR Alessi, ... Nature Communications 8 (1), 830, 2017	284	2017
E3 ligase ligands for PROTACs: how they were found and how to discover new ones T Ishida, A Ciulli SLAS DISCOVERY: Advancing the Science of Drug Discovery 26 (4), 484-502, 2021	270	2021
Targeting Cullin-RING E3 ubiquitin ligases for drug discovery: structure, assembly and small-molecule modulation E Bulatov, A Ciulli Biochemical Journal 467 (3), 365-386, 2015	238	2015
Impact of target warhead and linkage vector on inducing protein degradation: comparison of bromodomain and extra-terminal (BET) degraders derived from triazolodiazepine (JQ1 … KH Chan, M Zengerle, A Testa, A Ciulli Journal of medicinal chemistry 61 (2), 504-513, 2018	230	2018
Dissecting fragment-based lead discovery at the von Hippel-Lindau protein: hypoxia inducible factor 1α protein-protein interface I Van Molle, A Thomann, DL Buckley, EC So, S Lang, CM Crews, A Ciulli Chemistry & biology 19 (10), 1300-1312, 2012	227	2012
Potent and selective chemical probe of hypoxic signalling downstream of HIF-α hydroxylation via VHL inhibition J Frost, C Galdeano, P Soares, MS Gadd, KM Grzes, L Ellis, O Epemolu, ... Nature communications 7 (1), 13312, 2016	223	2016
Molecular recognition of ternary complexes: a new dimension in the structure-guided design of chemical degraders SJ Hughes, A Ciulli Essays in biochemistry 61 (5), 505-516, 2017	217	2017
Structure‐based design of a macrocyclic PROTAC A Testa, SJ Hughes, X Lucas, JE Wright, A Ciulli Angewandte Chemie 132 (4), 1744-1751, 2020	209	2020
Compounds and methods for the enhanced degradation of targeted proteins and other polypeptides by an E3 ubiquitin ligase CM Crews, D Buckley, A Ciulli, W Jorgensen, PC Gareiss, I Van Molle, ... US Patent 10,730,862, 2020	193	2020
Cyclic and macrocyclic peptides as chemical tools to recognise protein surfaces and probe protein–protein interactions TAF Cardote, A Ciulli ChemMedChem 11 (8), 787-794, 2016	190	2016
Application of Fragment Growing and Fragment Linking to the Discovery of Inhibitors of Mycobacterium tuberculosis Pantothenate Synthetase This research was supported by the … AW Hung, HL Silvestre, S Wen, A Ciulli, TL Blundell, C Abell Angewandte Chemie-German Edition 121 (45), 8604, 2009	188	2009
Trivalent PROTACs enhance protein degradation via combined avidity and cooperativity S Imaide, KM Riching, N Makukhin, V Vetma, C Whitworth, SJ Hughes, ... Nature chemical biology 17 (11), 1157–1167, 2021	178	2021

El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.

Artículos 1–20

Citas por año

Citas duplicadas

Citas combinadas

Añadir coautoresCoautores

Seguir

Citado por

Coautores